Author:
Rommer P. S., ,Dörner T.,Freivogel K.,Haas J.,Kieseier B. C.,Kümpfel T.,Paul F.,Proft F.,Schulze-Koops H.,Schmidt E.,Wiendl H.,Ziemann U.,Zettl U. K.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Immunology,Immunology and Allergy,Neuroscience (miscellaneous)
Reference38 articles.
1. Beres SJ, Graves J, Waubant E (2014) Rituximab use in pediatric central demyelinating disease. Pediatr Neurol 51(1):114–118
2. Boster A, Ankeny DP, Racke MK (2010) The potential role of B cell-targeted therapies in multiple sclerosis. Drugs 70:2343–2356
3. Carmona L, de la Vega M, Ranza R, Casado G, Titton DC, Descalzo MÁ, Gómez-Reino J (2014) BIOBADASER, BIOBADAMERICA, and BIOBADADERM: safety registers sharing commonalities across diseases and countries. Clin Exp Rheumatol 32(5 Suppl 85):S-163–S-167
4. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517
5. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64(7):1270–1272
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献